Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


Articles published in Thyroid

Retrieve available abstracts of 44 articles:
HTML format



Single Articles


    November 2022
  1. SEIB CD, Meng T, Cisco RM, Lin DT, et al
    Risk of permanent hypoparathyroidism requiring calcitriol therapy in a population-based cohort of adults older than 65 undergoing total thyroidectomy for Graves' disease.
    Thyroid. 2022 Nov 23. doi: 10.1089/thy.2022.0140.
    PubMed     Abstract available


  2. MERAKCHI K, Djerbib S, Dumont JE, Miot F, et al
    Severe autoimmune thyroiditis in transgenic NOD.H2(h4) mice expressing interleukin-4 in the thyroid.
    Thyroid. 2022 Nov 23. doi: 10.1089/thy.2022.0448.
    PubMed     Abstract available


  3. CASANY-FERNANDEZ R, Gascon-Gimenez F, Matarredona Solaz EJ, Pardo Lozano F, et al
    REMISSION OF GRAVES DISEASE AFTER INITIATION OF OCRELIZUMAB IN PATIENTS WITH MULTIPLE SCLEROSIS.
    Thyroid. 2022 Nov 23. doi: 10.1089/thy.2022.0398.
    PubMed     Abstract available


    October 2022
  4. HALADA S, Baran J, Isaza A, Patel T, et al
    Impact of Definitive Surgery for Graves' Disease on Adolescent Disease-Specific Quality of Life and Psychosocial Functioning.
    Thyroid. 2022 Oct 17. doi: 10.1089/thy.2022.0334.
    PubMed     Abstract available


    September 2022
  5. AHN HY, Lee J, Lee JK
    Predictive model for Graves' ophthalmopathy in patients with new-onset Graves' disease.
    Thyroid. 2022 Sep 21. doi: 10.1089/thy.2022.0280.
    PubMed     Abstract available


  6. SUZUKI N, Inoue K, Yoshimura R, Kinoshita A, et al
    The Mediation Role of TRAb in the Relationship between Age and Severity of Hyperthyroidism in Graves' Disease.
    Thyroid. 2022 Sep 8. doi: 10.1089/thy.2022.0252.
    PubMed     Abstract available


    August 2022
  7. KEEFE G, Culbreath K, Cherella CE, Smith JR, et al
    Autoimmune Thyroiditis and Risk of Malignancy in Children with Thyroid Nodules.
    Thyroid. 2022 Aug 11. doi: 10.1089/thy.2022.0241.
    PubMed     Abstract available


    July 2022
  8. LI L, Chen X, Li B, Liu D, et al
    Effect of Inactivated SARS-CoV-2 Vaccine on Thyroid Function and Autoimmunity within 28 days after the Second Dose.
    Thyroid. 2022 Jul 21. doi: 10.1089/thy.2022.0101.
    PubMed     Abstract available


  9. POPPE K
    Are live-birth rates reduced in euthyroid women with thyroid autoimmunity treated with an assisted reproductive technology? The Janus face of a meta-analysis.
    Thyroid. 2022 Jul 12. doi: 10.1089/thy.2022.0370.
    PubMed     Abstract available


  10. BUSNELLI A, Beltratti C, Cirillo F, Bulfoni A, et al
    IMPACT OF THYROID AUTOIMMUNITY ON ASSISTED REPRODUCTIVE TECHNOLOGY OUTCOMES AND OVARIAN RESERVE MARKERS: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS.
    Thyroid. 2022 Jul 12. doi: 10.1089/thy.2021.0656.
    PubMed     Abstract available


    June 2022
  11. MCLACHLAN SM, Rapoport B
    Discoveries in Thyroid Autoimmunity in the Past Century.
    Thyroid. 2022 Jun 29. doi: 10.1089/thy.2022.0275.
    PubMed     Abstract available


  12. HOU X, Guan H, Sun S, Shi Y, et al
    Outcomes of Early-pregnancy Antithyroid Drug Withdrawal in Graves' Disease: A Preliminary Prospective Follow-up Study.
    Thyroid. 2022 Jun 1. doi: 10.1089/thy.2022.0088.
    PubMed     Abstract available


    April 2022
  13. HUANG Y, Wu Y, Zhang S, Lu Y, et al
    Immunophenotype of lacrimal glands in Graves orbitopathy: Implications for the pathogenesis of Th1 and Th17 immunity.
    Thyroid. 2022 Apr 25. doi: 10.1089/thy.2021.0671.
    PubMed     Abstract available



  14. Correction to: Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy by Vannucchi, et al. Thyroid 2021;31(5):821-828; doi: 10.1089/thy.2020.0269.
    Thyroid. 2022 Apr 25. doi: 10.1089/thy.2020.0269.
    PubMed    


  15. ALVAREZ DE LA SIERRA D, Marin-Sanchez A, Gomez-Brey A, Bello I, et al
    LYMPHOCYTIC THYROIDITIS TRANSCRIPTOMIC PROFILES SUPPORT THE ROLE OF CHECKPOINT PATHWAYS AND B CELLS IN PATHOGENESIS.
    Thyroid. 2022 Apr 10. doi: 10.1089/thy.2021.0694.
    PubMed     Abstract available


  16. MORSHED SA, Ma R, Latif R, Davies TF, et al
    Mechanisms in Graves Eye Disease: Apoptosis as the End Point of Insulin-Like Growth Factor 1 Receptor Inhibition.
    Thyroid. 2022;32:429-439.
    PubMed     Abstract available


    March 2022
  17. SUZUKI N, Watanabe N, Noh JY, Yoshimura R, et al
    The relationship between primary thyroid lymphoma and various types of thyroid autoimmunity: A retrospective cohort study of 498 cases, including 9 cases with Graves' disease.
    Thyroid. 2022 Mar 1. doi: 10.1089/thy.2021.0613.
    PubMed     Abstract available


    February 2022
  18. MOSAFERI T, Tsai K, Sovich S, Wilhalme H, et al
    Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism is Distinct from Hashimoto's Thyroiditis.
    Thyroid. 2022 Feb 24. doi: 10.1089/thy.2021.0685.
    PubMed     Abstract available


    December 2021
  19. WOO T, Li C, Ganesananthan S, Rajendram R, et al
    The Effect of Ophthalmic Surgery for Graves' Orbitopathy on Quality of Life - A Systematic Review and Meta-analysis.
    Thyroid. 2021 Dec 8. doi: 10.1089/thy.2021.0411.
    PubMed     Abstract available


  20. SUTOH Y, Komaki S, Yamaji T, Suzuki S, et al
    Low MICA gene expression confers an increased risk of Graves' disease: a Mendelian randomization study.
    Thyroid. 2021 Dec 3. doi: 10.1089/thy.2021.0417.
    PubMed     Abstract available


    November 2021
  21. PHILIPP S, Horstmann M, Hose M, Daser A, et al
    An early wave of macrophage infiltration intertwined with antigen specific proinflammatory T-cells and browning of adipose tissue characterizes the onset of orbital inflammation in a mouse model of Graves' orbitopathy.
    Thyroid. 2021 Nov 13. doi: 10.1089/thy.2021.0464.
    PubMed     Abstract available


    October 2021
  22. STAN MN, Algeciras-Schimnich A, Murthy V, Thapa P, et al
    Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease.
    Thyroid. 2021 Oct 29. doi: 10.1089/thy.2021.0299.
    PubMed     Abstract available


  23. KRIEGER CC, Kahaly G, Azam A, Klubo-Gwiezdzinska J, et al
    Graves' Autoantibodies Exhibit Different Stimulating Activities in Cultures of Thyrocytes and Orbital Fibroblasts Not Reflected by Clinical Assays.
    Thyroid. 2021 Oct 29. doi: 10.1089/thy.2021.0326.
    PubMed     Abstract available


  24. GUNN AH, Frisco N, Thomas S, Stang M, et al
    Patient-Reported Outcomes Following Total Thyroidectomy for Graves' Disease.
    Thyroid. 2021 Oct 19. doi: 10.1089/thy.2021.0285.
    PubMed     Abstract available


  25. WANG X, Yang S, Ye H, Chen J, et al
    Disulfiram exerts antiadipogenic, anti-inflammatory, and antifibrotic therapeutic effects in an in vitro model of Graves' orbitopathy.
    Thyroid. 2021 Oct 4. doi: 10.1089/thy.2021.0246.
    PubMed     Abstract available


  26. TAPROGGE J, Gape PM, Carnegie-Peake L, Murray I, et al
    A systematic review and meta-analysis of the relationship between the radiation absorbed dose to the thyroid and response in patients treated with radioiodine for Graves' disease.
    Thyroid. 2021 Oct 1. doi: 10.1089/thy.2021.0302.
    PubMed     Abstract available


  27. IPPOLITO S, Di Dalmazi G, Pani F, Sabini E, et al
    Distinct cytokine signatures in thyroiditis induced by PD-1 or CTLA-4 blockade: insights from a new mouse model.
    Thyroid. 2021 Oct 1. doi: 10.1089/thy.2021.0165.
    PubMed     Abstract available


    September 2021
  28. HOMMA H, Watanabe M, Inoue N, Isono M, et al
    Polymorphisms in vitamin A-related genes and their functions in autoimmune thyroid disease.
    Thyroid. 2021 Sep 2. doi: 10.1089/thy.2021.0312.
    PubMed     Abstract available


    August 2021
  29. WAN S, Liu L, Ren B, Qu M, et al
    DNA methylation patterns in the HLA-DPB1 and PDCD1LG2 gene regions in patients with autoimmune thyroiditis from different water iodine areas.
    Thyroid. 2021 Aug 12. doi: 10.1089/thy.2021.0221.
    PubMed     Abstract available


    July 2021
  30. PILLI T, Dalmazio G, Porcelli B, Cantara S, et al
    Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases.
    Thyroid. 2021 Jul 19. doi: 10.1089/thy.2021.0170.
    PubMed     Abstract available


  31. OKAZAKI-HADA M, Maruoka A, Yamamoto M, Ito M, et al
    Poorly differentiated thyroid carcinoma coexisting with Graves' disease involving T3 thyrotoxicosis due to increased D1 and D2 activities.
    Thyroid. 2021 Jul 18. doi: 10.1089/thy.2021.0082.
    PubMed     Abstract available


  32. CAPPELLANI D, De Marco G, Ferrarini E, Torregrossa L, et al
    Identification of two different phenotypes of patients with amiodarone-induced thyrotoxicosis and positive thyrotropin receptor antibody tests.
    Thyroid. 2021 Jul 16. doi: 10.1089/thy.2021.0118.
    PubMed     Abstract available


  33. EKRONARONGCHAI S, Palaga T, Saonanon P, Pruksakorn V, et al
    Histone Deacetylase 4 Controls Extracellular Matrix Production in Orbital Fibroblasts from Graves' Ophthalmopathy Patients.
    Thyroid. 2021 Jul 8. doi: 10.1089/thy.2020.0948.
    PubMed     Abstract available


    June 2021
  34. RYDER M, Wentworth M, Algeciras-Schimnich A, Morris JC 3rd, et al
    Blocking the TSH receptor with K1-70 in a patient with follicular thyroid cancer, Graves' disease and Graves' ophthalmopathy.
    Thyroid. 2021 Jun 11. doi: 10.1089/thy.2021.0053.
    PubMed     Abstract available


    May 2021
  35. KIM J, Choi MS, Park J, Park H, et al
    Changes in Thyroid Stimulating Hormone Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease.
    Thyroid. 2021 May 5. doi: 10.1089/thy.2020.0756.
    PubMed     Abstract available


    April 2021
  36. SUZUKI N, Noh JY, Yoshimura R, Mikura K, et al
    Does age or sex relate to severity or treatment prognosis in Graves' disease?
    Thyroid. 2021 Apr 21. doi: 10.1089/thy.2020.0881.
    PubMed     Abstract available


  37. VERA-LASTRA O, Ordinola Navarro A, Cruz Dominguez MP, Medina G, et al
    Two cases of Graves' disease following SARS-CoV-2 vaccination: An autoimmune/inflammatory syndrome induced by adjuvants.
    Thyroid. 2021 Apr 15. doi: 10.1089/thy.2021.0142.
    PubMed     Abstract available



  38. Correction to: Influence of Dietary Habits on Oxidative Stress Markers in Hashimoto's Thyroiditis by Ruggeri et al. Thyroid 2021;31:96-105. DOI: 10.1089/thy.2020.0299.
    Thyroid. 2021;31:709.
    PubMed    


  39. VAN REGEMORTER E, Joris V, Van Regemorter V, Marique L, et al
    Downregulation of Caveolin-1 and Upregulation of Deiodinase 3, Associated with Hypoxia-Inducible Factor-1alpha Increase, Are Involved in the Oxidative Stress of Graves' Orbital Adipocytes.
    Thyroid. 2021;31:627-637.
    PubMed     Abstract available


    December 2020
  40. SCAPPATICCIO L, Longo M, Maiorino MI, Pernice V, et al
    Abnormal liver blood tests in patients with hyperthyroidism: systematic review and meta-analysis.
    Thyroid. 2020 Dec 16. doi: 10.1089/thy.2020.0715.
    PubMed     Abstract available


    November 2020
  41. GUO J, Teng D, Shi X, Li Y, et al
    Exposure to the Chinese Great Famine in early life and thyroid function and disorders in adulthood: a cross-sectional study.
    Thyroid. 2020 Nov 2. doi: 10.1089/thy.2020.0325.
    PubMed     Abstract available


    April 2020
  42. AZIZI F
    Long-term treatment of hyperthyroidism with antithyroid drugs: 35 years of personal clinical experience.
    Thyroid. 2020 Apr 7. doi: 10.1089/thy.2019.0814.
    PubMed     Abstract available


  43. POZDEYEV N, Erickson T, Zhang L, Ellison K, et al
    Comprehensive Immune Profiling of Medullary Thyroid Cancer.
    Thyroid. 2020 Apr 3. doi: 10.1089/thy.2019.0604.
    PubMed     Abstract available


    March 2020
  44. TAKYAR M, Rahmani M, Amouzegar A, Madreseh E, et al
    Parity and incidence of thyroid autoimmunity a population-based study Tehran thyroid study (TTS).
    Thyroid. 2020 Mar 11. doi: 10.1089/thy.2019.0440.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: